InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: afxm post# 131

Monday, 12/05/2011 5:07:03 PM

Monday, December 05, 2011 5:07:03 PM

Post# of 212
approved earlier.
# Monday, December 5, 10:44 AM Incyte (INCY -2.8%) trades lower after Citi cuts the shares the shares to Neutral from Buy. Citi cites limited market potential for Jakafi after conducting a survey that showed only 35% of physicians were expected to prescribe the drug to their patients. Comment! [On the Move, Healthcare]
# Wednesday, November 16, 11:29 AM Incyte (INCY) announces the FDA's approval of Jakafi, the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis. Trading halted. Comment! [Healthcare]
# Thursday, October 27, 8:31 AM Incyte (INCY): Q3 EPS of -$0.42 beats by $0.03. Revenue of $16.8M (-6% Y/Y) beats by $0.3M. (PR) Comment! [Earnings, Healthcare]
source: alpha
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INCY News